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Human hair follicles exhibit a complex pattern of sequential hair keratin expression in the hair matrix, cuticle, and
cortex. In pilomatricomas, that is, benign skin tumors thought to arise from germinative matrix cells of the hair
follicle and retaining morphological signs of cortical differentiation, this differential hair keratin pattern has been
shown to be faithfully preserved in the lower and upper transitional cell compartments of the tumors. Here we show
that also the co-expression of hair keratin hHa5 with its regulatory nuclear homeoprotein HOXC13 in matrix cells of
the hair follicle is maintained in lower transitional cells of pilomatricomas. In contrast, the nuclear co-expression of
LEF1 and b-catenin, which in the hair follicle has been postulated to initiate cortex cell differentiation through the
induction of hair keratin hHa1 expression (Merill et al, Genes Dev 15:1688–1705, 2001), is not preserved in upper
transitional cells of pilomatricomas. Although these cells correctly express hHa1, they are completely devoid of
LEF1 and nuclear LEF1/b-catenin co-expression is shifted to a subpopulation of hair keratin-free basaloid cells of
the tumors. These data imply that unlike the normal hair follicle, cortical differentiation in pilomatricomas is not
under the control of the canonical Wnt signaling pathway.
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The human hair keratin family consists of 9 type I and 6 type
II members, whose genes are clustered within the type I and
type II epithelial keratin gene domains on chromosomes
17q21.2 and 12q13.3, respectively (Rogers et al, 1998,
2000). A comparison of the two hair keratin gene domains
reveals striking similarities regarding their physical organi-
zation into distinct gene groups. One end of each domain
contains groups of essentially three highly related genes
(type I: hHa1, hHa4, and isoforms hHa3-I/hHa3-II; type II:
hHb3, hHb6, hHb1). These are all expressed in the hair
cortex, with hHa1 starting in the pre-cortex and the
remaining members being induced consecutively higher
up (Langbein et al, 1999). The opposite ends of the two
clusters harbor groups of three distinctly less related genes
(type I: hHa6, hHa5, hHa2; type II: hHb2, hHb4, hHb5),
which exhibit a highly heterogeneous expression pattern in
the matrix, lower cuticle, and cortex of the hair follicle
(Langbein et al, 2001).
Previous studies in our laboratories have shown that the
sequential hair keratin expression in the human hair follicle
is faithfully preserved in pilomatricomas (Cribier et al, 2001).
Typically, these benign skin tumors that are thought to arise
from the germinative and matrix compartment of the hair
follicles, exhibit morphological signs of differentiation of
basaloid cells towards a cortical cell type in the so-called
transitional cell compartment (Ackermann et al, 2001). In
these tumors, both major and minor hair keratins of the
trichocytic compartment of the hair follicle are sequentially
expressed in the right order in lower and upper transitional
cells, respectively (Cribier et al, 2001).
At present, the molecular mechanisms and factors
regulating the complex keratin expression in the hair-form-
ing compartment of the follicle are poorly understood. We
have recently shown that the homeobox protein HOXC13
co-localizes with the matricial and cuticular keratins hHa5
and hHa2 and is able to regulate directly their expression in
the lower hair forming compartment by binding to distinct
response elements in the proximal promoters of the genes
(Jave-Suarez et al, 2002). In addition, we found that hair
keratin hHa7 displays an androgen receptor-mediated
expression in the medulla of sexual hairs (Jave-Suarez
et al, 2004). Moreover, the forkhead transcription factor
Foxn1 has been implicated in controlling the expression of a
number of cortex keratins (Meier et al, 1999; Schlake et al,
2000).
Recently, it has been proposed that the canonical Wnt
signaling pathway is involved in the commitment of late hair
matrix cells to cortical differentiation, in that the down-
stream effectors b-catenin and LEF1 induce the expression
of pre-cortical hair keratins (Das Gupta and Fuchs, 1999;
Merill et al, 2001). This assumption was based on (i) the
presence of LEF1 binding sites in the proximal promoters of
nearly all hair keratin genes (Zhou et al, 1995; Rogers et al,
1998, 2000), (ii) the demonstration that the promoter of
the pre-cortical keratin gene mHa1 could be activated
by LEF1/b-catenin in epidermal keratinocytes (Merill et al,
2001), and (iii) the visualization of nuclear LEF1 and
b-catenin in mouse pre-cortex cells, grouped into a narrow
triangle immediately above the apex of the dermal papilla
(Das Gupta and Fuchs, 1999; Merill et al, 2001). In addition,
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studies in transgenic mice revealed that the mutation of the
LEF1 binding site in a type II cortex keratin gene resulted in
an apparent reduction of promoter activity (Dunn et al, 1998).
Relying on the preservation of sequential hair keratin
synthesis in pilomatricomas, we undertook a comparative
immunohistochemical study on the expression of the matrix
keratin hHa5 and the pre-cortex keratin hHa1 in both hair
follicles and pilomatricomas relative to their putative
regulatory factors HOXC13, and LEF-1/b-catenin. We show
that in both hair follicles and pilomatricomas, HOXC13
remains co-expressed with hHa5, but provide evidence that
hHa1 expression appears to be differently controlled in hair
follicles and pilomatricomas.
Results
Hair keratin expression in hair follicles and pilomatri-
comas Formalin-fixed paraffin sections of human hair
follicles and pilomatricomas were first investigated for the
expression of the nuclear proliferation marker Ki67. In hair
follicles, Ki67 occurred predominantly in the nuclei of
germinative cells as well as in matrix cells, preferentially
those lying close to the dermal papilla (Fig 1A). In serial
sections of pilomatricomas, nuclear Ki67 was restricted to
the proliferative, basaloid cells of the tumors (Figs 2A and
4A). Reassessment of hHa5 expression in the hair follicles
(Langbein et al, 1999) confirmed that this hair keratin
occurred above the germinative cell compartment in the
matrix, cuticle, and pre-cortex cells (Fig 1B). hHa5 was
absent from most cells lining the dermal papilla, although
some of them had already begun to express this hair keratin
(small arrows in Fig 1B). The scalp hair follicle shown here
contained a prominent medulla, which was devoid of hHa5
(Fig 1B). As previously described (Langbein et al, 1999), the
synthesis of hair keratin hHa1 began rather abruptly in the
lower cortex region, approximately at the height where the
intensity of pre-cortical hHa5 staining decreased (Fig 1C). In
pilomatricomas, hHa5 expression was only seen in transi-
tional cells, immediately above the Ki67-positive basaloid
cell compartment with upper transitional cells remaining
unstained (Fig 2C). In contrast, these cells were clearly
recognized by the antibody against the cortical hHa1
keratin, whereas shadow cells were not stained (Fig 2D).
Transcription factor expression in hair follicles and
pilomatricomas In accordance with a previous study on
frozen scalp sections (Jave-Suarez et al, 2002), the
homeoprotein HOXC13 was completely absent from germi-
native cells but was strongly expressed in the nuclei of the
matrix, pre-cortex, and cuticle cells of the hair follicle
(Fig 1D). The serial analysis of various pilomatricomas for
HOXC13 expression demonstrated that this transcription
factor was specifically located in the nuclei of lower
transitional cells of the tumors, which were less densely
packed than the subjacent basaloid cells (Fig 2B and 3B).
Thus in both hair follicles and pilomatricomas, nuclear
HOXC13 expression coincided with that of its target gene
hHa5 (compare Figs 1B, D and 2B, C).
In contrast, the expression of LEF1 was clearly different
in hair follicles and pilomatricomas. As shown in Fig 1E, the
LEF1 expression pattern in the hair follicles represented a
perfect duplicate of that of HOXC13 in that it specifically
took place in the nuclei of the matrix, cuticle, and pre-cortex
cells. At lower dilutions, the antibody produced a weak
nuclear staining also in cells of the germinative compart-
ment (Fig 1F). Although nuclear HOXC13 has previously been
demonstrated in the hair medulla (Jave-Suarez et al, 2002),
LEF1 appeared to be not expressed in this compartment
of the human follicle (Fig 1F ). Essentially similar LEF1
expression patterns have repeatedly been described in
mouse hair follicles (Das Gupta and Fuchs, 1999; Merill
et al, 2001). Consequently, as with Hoxc13, one would have
expected LEF1 to occur predominantly in the nuclei of lower
transitional cells of pilomatricomas. Instead, confirming a
previous study in these tumors (Chan et al, 1999), nuclear
LEF1 expression was found in the basaloid cells of
pilomatricomas (Figs 3A and 4B), and the neighboring
HOXC13-expressing lower transitional cells were devoid of
this factor (compare Fig 3A and B).
This deviation in pilomatricomas from the follicular
expression pattern was even more pronounced for b-
catenin. As there are also conflicting data on nuclear
b-catenin expression in formalin-fixed paraffin sections of
the hair follicles (Moreno-Bueno et al, 2001; Park et al, 2001;
Tsuji et al, 2001), b-catenin expression was explored by
means of two different antibodies both yielding, however,
comparable results. At high dilutions, the antibodies
revealed a strong cytoplasmic staining only in the matrix,
including the cells lining the dermal papilla, the cuticle, and
the entire cortex, and the germinative compartment of the
hair follicles appeared essentially unstained. There was also
no staining in the inner root sheath (IRS), but suprabasal
cells of the multilayered outer root sheath (ORS) above the
pre-cortex region exhibited a weak cytoplasmic reaction
(Fig 1G). In contrast, at lower dilutions, both antibodies also
stained the cytoplasm of germinative cells and the
membranes of lower ORS cells, and the entire IRS remained
unstained (Fig 1H). In both cases, however, higher magnifi-
cations of the sections revealed few individual cells scattered
throughout the pre- to mid-cortex region, which exhibited a
faint nuclear staining (arrowheads in Fig 1I ). Essentially sim-
ilar patterns of sporadic nuclear b-catenin expression and
hence, only sporadic co-expression with LEF1 in pre- to mid-
cortex cells have also been reported in several previous
studies in which paraffin sections of the human hair follicles
were subjected to microwave-mediated antigen retrieval
(Moreno-Bueno et al, 2001; Park et al, 2001; Ridanpa¨a¨ et al,
2001). Only one recent study, which used pressure cooker
treatment of paraffin sections of human hair follicles, revealed
a nuclear b-catenin expression pattern in pre-cortex cells
(Tsuji et al, 2001) that seemed to resemble the expression
pattern reported in mouse hair follicles (Das Gupta and
Fuchs, 1999; Merill et al, 2001; Niemann et al, 2002).
In serial sections of pilomatricomas, a strong cytoplas-
mic b-catenin expression occurred in the uppermost
transitional cells of the tumors (Fig 3C, arrowheads, and
Fig 4C). The tumor in Fig 4C contained a rather large
compartment of upper transitional cells, in which the
staining intensity slightly decreased along with the differ-
entiation of the cells into shadow cells. In contrast, the
tumor in Fig 3C exhibited only a narrow band of strongly
b-catenin-positive upper transitional cells adjacent to the
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broader band of HOXC13-positive lower transitional cells (Fig
3B). Staining of tissue sections of the pilomatricoma shown
in Fig 4 with the hHa1 antibody revealed a virtually complete
overlap of cytoplasmic hHa1 and b-catenin expression in
upper transitional cells, including the fading of the hHa1
staining towards shadow cell differentiation (Fig 4D). De-
pending on the b-catenin antibody used, the com-
partments below the upper transitional cells of the pilo-
matricomas displayed a much weaker or almost absent
cytoplasmic b-catenin staining (Figs 3C and 4C). A narrower
inspection of the section in Fig 4C (arrows in inset), however,
showed that b-catenin clearly exhibited nuclear expression
either in single or groups of LEF1-expressing basophilic cells
that were, however, not seen in the tumor in Fig 3C. Also,
these b-catenin expression characteristics, including the
varying nuclear b-catenin expression in basaloid cells, were
essentially comparable with those reported in previous
pilomatricoma studies (Moreno-Bueno et al, 2001; Park et
al, 2001; Tsuji et al, 2001).
Discussion
In this study, we confirmed that the sequential expression of
the hair matrix keratin hHa5 and the pre-cortex keratin hHa1
in the human hair follicle was maintained in intermediate
Figure 1
Expression studies in hair follicles. Normal
human scalp sections were reacted with the
following antibodies. (A) Ki67, (B) hHa5––note
the presence of hHa5 in some cells lining the
dermal papilla (arrows) but absence of this
keratin in the medulla, (C) hHa1, (D) HOXC13,
(E, F) LEF1––note the apparent lack of LEF1 in
the medulla of the hair follicle of panel F, (G) b-
catenin (Sigma antibody; see Material and
Methods), (H) b-catenin (Transduction La-
boratories antibody; see Material and Meth-
ods), (I) b-catenin, higher magnification of
the pre-cortex region in H. Cells exhibiting
nuclear b-catenin location are indicated by
arrowheads. gc, germinative compartment;
ma, matrix; me, medulla; co, cortex; cu, cuti-
cle; pc, pre-cortex; irs, inner root sheath;
ors, outer root sheath; dp, dermal papilla.
Bars¼100 mm (A–F,H); 200 mm (G); 50 mm (I).
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maturation stage pilomatricomas in which the two hair
keratins were consecutively expressed in lower and upper
transitional cells, respectively. This finding is in line with the
site-specific preservation of the expression of a variety of
other factors in hair follicles and pilomatricomas. Thus, the
transcription factor p63 was found to be expressed in the
germinative cell compartment of the hair follicles, and in
pilomatricomas it occurred specifically in basaloid cells
(Tsujita-Kyutoku et al, 2003). Here we showed that the
expression of the proliferation marker Ki67 involved the
same tissue compartments. Furthermore, it has been
demonstrated that involucrin that, similar to hair keratin
hHa1, was expressed in cortex cells of the hair follicle,
specifically occurred in the uppermost transitional cells of
pilomatricomas (Hashimoto et al, 1987; Murthy et al, 1993;
Watanabe et al, 1994).
Collectively, these findings indicate that germinative cells
of the hair follicle bulb correspond to basaloid cells of
pilomatricomas, and hair follicle matrix and cortex cells
have their counterparts in the lower and upper transitional
cell compartments of the tumors. These data also suggest
that regulatory processes involved in the site-specific
expression of transcription factors and structural proteins
in the hair follicles should be maintained in pilomatricomas.
Indeed, we were able to show that this held true for the
recently identified transcription factor HOXC13 (Jave-Suarez
Figure 2
Expression studies in pilomatricomas. Serial
sections of a pilomatricoma were reacted with
antibodies against (A) Ki67, (B) HOXC13, (C)
hHa5, (D) hHa1. bc, basaloid cells, ltc, lower
transitional cells; utc, upper transitional cells.
Bars¼ 100 mm.
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et al, 2002), which in both hair follicles and pilomatricomas
was co-expressed with its main target gene hHa5 in the
nuclei of matrix and lower transitional cells, respectively. In
contrast, this was not the case for the downstream effectors
LEF1 and b-catenin of the canonical Wnt signaling pathway,
which in mouse hair follicles are thought to commit late
matrix cells to cortex differentiation by inducing hair keratin
hHa1 expression through a LEF1 binding site in the
promoter of the hHa1 gene (Das Gupta and Fuchs, 1999;
Merill et al, 2001). Apart from the difficulties we and others
(Moreno-Bueno et al, 2001; Park et al, 2001; Ridanpa¨a¨ et al,
2001; Tsuji et al, 2001) faced to reproduce in the human hair
follicles the particular pattern of nuclear LEF1/b-catenin co-
localization in pre-cortex cells of mouse hair follicles, we
were unable to detect nuclear LEF1/b-catenin in upper,
hHa1-positive transitional cells of pilomatricomas. Instead,
b-catenin expression in these cells was clearly cytoplasmic
and, when found, nuclear LEF1 and b-catenin expressions
were entirely restricted to the hair keratin-free cells of the
basaloid cell compartment of the tumors. Most probably,
the latter was due to the acquisition of b-catenin stabilizing
mutations in the CTNNB1 gene, which have been shown to
occur in 75–100% of pilomatricomas (Chan et al, 1999;
Kajino et al, 2001, and own unpublished data). Stabilized
b-catenin is thought to entail the activation of LEF1 target
genes in germinative cells of the hair follicles leading to the
development and sustained growth of pilomatricomas
(Chan et al, 1999). The observed alterations of nuclear
LEF1 and b-catenin expression in hair follicles and
pilomatricomas imply that contrary to the site-specific
preservation of HOXC13/hHa5 expression in both tissues,
the postulated regulation of hHa1 expression by the nuclear
LEF-1/b-catenin complex in pre-cortex cells of the hair
follicles is not maintained in upper transitional cells of
pilomatricomas. Instead, in these tumors, other regulatory
pathways must be involved in both the induction of a
cortex-like differentiation concomitant with the site-specific
expression of hHa1. Conceptually, Foxn1 may be a possible
candidate factor, since it has been found to affect the
expression of a variety of murine cortex keratins (Meier et al,
1999; Schlake et al, 2000). In addition, it has recently been
shown that the homeoprotein HOXC12 is expressed
Figure 3
Expression studies in pilomatricomas. Serial
sections of a pilomatricoma were reacted with
antibodies against (A) LEF1, (B) HOXC13, (C) b-
catenin (Transduction Laboratories antibody).
The dotted lines in panels A and B delineate the
boundary between basaloid and lower transi-
tional cells. The arrows in C indicate a small
band of strongly b-catenin-positive upper tran-
sitional cells. Bars¼100 mm.
Figure4
Expression studies in pilomatricomas. Serial
section of a pilomatricoma were reacted with
antibodies against (A) Ki67, (B) LEF1, (C) b-
catenin (Sigma antibody), (D) hHa1. The small
arrows in the inset of panel C denote cells or
cell groups expressing nuclear b-catenin.
Bars¼ 100 mm.
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subsequent to matricial HOXC13 in the entire cortex of
mouse hairs (Shang et al, 2001). Interestingly, potential Hox
binding sites are present in the proximal promoter of
HOXC13 as well as other cortex keratin genes (unpublished
data). Further studies are needed to gain an insight into the
role of these factors as well as their possible interplay with
LEF1 and/or b-catenin in the control of cortical differentia-
tion pathways of normal hair follicles and pilomatricomas.
Materials and Methods
Antibodies The following primary antibodies were used: mouse
monoclonal antibody Ki67 (Dako, Glostrup, Denmark) dilution 1:25;
guinea-pig antiserum against hHa5 (Langbein et al, 1999), dilution
1:400; mouse monoclonal antibody LHTric-1 against hHa1 (West-
gate et al, 1997), dilution 1:50; guinea-pig antiserum against human
Hoxc13 (Jave-Suarez et al, 2002), dilution 1:400; rabbit antiserum
292 against murine LEF1 (kindly provided by O. Huber, Berlin,
Germany), dilution 1:4000 and 1:6000; mouse monoclonal anti-
body, clone 14, against human b-catenin (Transduction Labora-
tories, Lexington, Kentucky, USA), dilution 1:1000; rabbit antiserum
against a synthetic peptide corresponding to the C-terminal region
(amino acids 768–781) of human/mouse b-catenin (Sigma, Saint
Louis, Michigan, USA), dilution 1:8000.
Immunohistochemistry In this study, we used normal human
scalp samples obtained from plastic surgery and 15 pilomatrico-
mas of the intermediate maturation stage (Kaddu et al, 1996),
selected from the skin tumor collection of the Laboratory of
Cutaneous Histopathology, Strasbourg, France. As there is
evidence that the reliable detection of nuclear b-catenin is strongly
compromised in frozen sections (Munne´ et al, 1999), the material
was fixed in formalin and embedded in paraffin using standard
procedures (Cribier et al, 2001). Immunohistochemistry on five
tissue sections was performed using a conventional labeled
streptavidin–biotin method (LSAB-2 System; Dako, Carpintera,
California, USA). All sections were heated for 35 min at 250 W in a
microwave oven either in citrate buffer at pH 6.0 (Ki67 antibody) or
in EDTA buffer at pH 8.00 (all other antibodies) (Cribier et al, 2001).
In addition, sections exposed to the hHa5, HOXC13, and LEF1
antibodies were treated with 0.1% trypsin for 3 min after
microwave heating. All antibodies were incubated at 41C for 24 h.
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